| NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
|---|---|---|---|---|---|---|
| 6505-00-767-3578 Item Description: Cyclophosphamide Fo | 6505 | 007673578 | M | Y | ||
| CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
| U | A | |||||
| Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
| NDC00087 0501 01 | 2 | 2 | 5 |
| MRC | Criteria | Characteristic |
|---|---|---|
| AGXW | PHYSICAL FORM | POWDER |
| AJCN | III PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 200.000 MILLIGRAMS CYCLOPHOSPHAMIDE, ANHYDROUS ACTIVE INGREDIENT |
| CBBL | FEATURES PROVIDED | STERILE |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| CQPQ | III WARNING AND CAUTION STATEMENTS | CHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 12 |
| CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | CYCLOPHOSPHAMIDE FOR INJECTION USP 200MG VIAL 12S PG |
| FEAT | SPECIAL FEATURES | VIAL W/NOT LESS THAN 15 ML OF VOLUME; NOTE: D |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| THPE | III THERAPEUTIC EQUIVALENT | NEOSAR BY ADRIA LABS.,INC.; CYTOXAN BY BRISTOL LABS.,INC. |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 200.000 MILLIGRAMS OF ACTIVE INGREDIENT |
Warrantied inventory at competitive prices
Search the world's largest inventory of electronic components by manufacturer, category or part number
All inventory ready to ship from our sellers
We sell only warrantied and traceable parts
Semiconductor's Certifications and Memberships
We are most trusted and leading distributor for aviation parts. You can get a quote within 15 minutes for your desired part. Quote Now!
Request for Quote